OPK

OPKO Health
NASDAQ

实时行情|Nasdaq Last Sale

1.305
-0.055
-4.04%
交易中 13:38 03/31 EDT
开盘
1.350
昨收
1.360
最高
1.350
最低
1.300
成交量
614.24万
成交额
--
52周最高
2.910
52周最低
1.300
市值
8.74亿
市盈率(TTM)
-2.4815
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测OPK价格均价为4.150,最高价位6.00,最低价为3.000。

EPS

OPK 新闻

更多
  • 四年来最低价!美国油价跌至2美元以下
  • 央视 · 44分钟前
  • 危险已经过去美股柳暗花明?经济学家:现在还是重个股轻指数
  • 新浪财经综合 · 48分钟前
  • 特朗普呼吁推出"大规模且大胆"的2万亿美元基建法案
  • 新浪美股 · 1小时前
  • 高盛预计美经济二季度萎缩34% 但将出现有史以来最快复苏
  • 新浪美股 · 1小时前

所属板块

制药
-0.28%
制药与医学研究
-0.59%

热门股票

代码
价格
涨跌幅

OPK 简况

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health), GeneDx and Laboratorio Bueno Salud. As of December 31, 2016, it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Biologics, hGH-CTP, Factor VII, Oxyntomodulin, active pharmaceutical ingredients, Oligonucleotide Therapeutics, NK-1 Program, Asthma and chronic obstructive pulmonary disease.
展开

微牛提供Opko Health Inc.(NASDAQ-OPK)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的OPK股票新闻,以帮助您做出投资决策。